Wednesday, July 8, 2026

pharma · Gout · Asthma

Sunshine Guojian Pharmaceutical

Sunshine Guojian Pharmaceutical is a pharma organization headquartered in FORT LAUDERDALE, FL, CN. Primary therapeutic focus areas include Gout, Asthma, Type 2 Diabetes, Dermatitis, Atopic, Chronic Hepatitis C. NovaPharm

FORT LAUDERDALE, FL, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
FORT LAUDERDALE, FL, CN
Programs
165
Drugs
80
Patents
121
Clinical program

Insulin degludec injection, RD15003

Phase 1 · mab · Type 2 Diabetes

Insulin degludec injection, RD15003 for Type 2 Diabetes is a Phase 1 program (mab) at Sunshine Guojian Pharmaceutical (Shanghai) Co., with 1 ClinicalTrials.gov record(s).

Internal code RD15003-P-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Phase
Phase 1
Modality
mab
Indication
Type 2 Diabetes
Status
completed
Trials
1